Real-time enrollment status for this relapsed or refractory t cell lymphoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:44 AM UTC
| NCT Number | NCT05079282 |
| Recruiting Status | Recruiting |
| Condition | Relapsed or Refractory T Cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 217 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Ono Pharmaceutical Co., Ltd. |
| Last Updated on CT.gov | February 13, 2026 (Feb 13, 2026) |
As of July 13, 2026: Clinical trial NCT05079282 is currently recruiting participants. This clinical trial study for relapsed or refractory t cell lymphoma is actively seeking new participants at 20 locations across the United States. The study is sponsored by Ono Pharmaceutical Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05079282 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05079282 was last updated Feb 13, 2026 (February 13, 2026). HelloStudys verifies this status automatically.